Patents by Inventor Marie Cumberbatch

Marie Cumberbatch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-inflammatory peptides
    Patent number: 8188053
    Abstract: The present invention relates, inter alia, to a method of ameliorating an inflammatory skin condition. Thus, the present invention provides a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 70 amino acids and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, and wherein the peptide is not that depicted in SEQ ID NO. 19. The present invention also relates to the use of a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 100 amino acids, and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, in the manufacture of a topical medicament for the treatment of an inflammatory skin condition.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: May 29, 2012
    Assignee: The University of Manchester
    Inventors: Marie Cumberbatch, Rebecca Jane Dearman, Ian Kimber, Russell Colin Viner
  • Anti-Inflammatory Peptides
    Publication number: 20090253631
    Abstract: The present invention relates, inter alia, to a method of ameliorating an inflammatory skin condition. Thus, the present invention provides a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 70 amino acids and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, and wherein the peptide is not that depicted in SEQ ID NO. 19. The present invention also relates to the use of a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 100 amino acids, and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, in the manufacture of a topical medicament for the treatment of an inflammatory skin condition.
    Type: Application
    Filed: December 4, 2006
    Publication date: October 8, 2009
    Inventors: Marie Cumberbatch, Rebecca Jane Dearman, Ian Kimber, Russell Colin Viner
  • METHOD FOR AMELIORATING AN INFLAMMATORY SKIN CONDITION
    Publication number: 20090203586
    Abstract: The present invention relates to the use of thioredoxin in the manufacture of a medicament suitable for application to a skin surface for ameliorating an inflammatory skin condition. The present invention further relates to a method of ameliorating an inflammatory skin condition comprising applying to a skin surface an effective amount of a composition comprising thioredoxin. The invention further relates to a pharmaceutical composition suitable for ameliorating an inflammatory skin condition comprising from 0.0001 to 0.5 w/v thioredoxin.
    Type: Application
    Filed: June 10, 2005
    Publication date: August 13, 2009
    Applicant: SYNGENTA LIMITED
    Inventors: Rebecca Jane Dearman, Marie Cumberbatch, Ian Kimber, Gregorio Del Val
  • LACTOFERRIN AS REGULATOR OF ALLERGEN-INDUCED TUMOR NECROSIS FACTOR-ALPHA PRODUCTION AND THERAPEUTIC APPLICATIONS
    Publication number: 20030190303
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating allergic disorders characterized by a local immune response including inflammatory skin reactions, asthma, and arthritis.
    Type: Application
    Filed: April 10, 1998
    Publication date: October 9, 2003
    Inventors: IAN KIMBER, MARIE CUMBERBATCH, REBECCA J. DEARMAN, ORLA M. CONNEELY, PAULINE WARD